Are you a U.S. biotech company concerned about study timelines, costs, patient recruitment, or maximizing the value of your asset in major markets like Japan or China? Running your study in Asia Pacific Japan may be your solution!

This spring, IQVIA Biotech is bringing the forefront of innovation to the United States from the JAPAC region. From April 23^rd  to April 30^th 2025, a team of experts from the JAPAC region will travel across key U.S. locations, engaging with biotech customers and showcasing how leveraging JAPAC opportunities can accelerate FDA and U.S. approvals.

Why attend IQVIA JAPAC Week?

Click hereor scan the QR code to register and be part of the future of healthcare!

Kind Regards,

Gerard Brett
Senior Vice President and Head  
IQVIA Biotech, JAPAC

iqviabiotech.com